Article Sidebar

pdf
Date Published: 20/12/2024
Abstract Views: 0
Views pdf: 0
DOI: https://doi.org/10.51298/vmj.v545i2.12248
Issue
Vol. 545 No. 2 (2024)
Section
Các bài báo
How to Cite
Teng, V., Trần, N. Ánh, & Nguyễn, T. C. (2024). PROGNOSTIC VALUE OF THE FIVE-VARIABLE MODEL FOR END-STAGE LIVER DISEASE (5VMELD) FOR PREDICTION OF MORTALITY ON THE PATIENTS WITH LIVER CIRRHOSIS. Vietnam Medical Journal, 545(2). https://doi.org/10.51298/vmj.v545i2.12248

PROGNOSTIC VALUE OF THE FIVE-VARIABLE MODEL FOR END-STAGE LIVER DISEASE (5VMELD) FOR PREDICTION OF MORTALITY ON THE PATIENTS WITH LIVER CIRRHOSIS

Virakseth Teng, Ngọc Ánh Trần, Thị Chi Nguyễn

Main Article Content

Abstract

Objective: To evaluate the results of the 5vMELD score in patients with cirrhosis compared with the MELD and MELDNa scores; to investigate the value of the 5VMELD score in prognosis in patients with cirrhosis.Subjects and methods: Cross-sectional descriptive study. The study subjects were patients diagnosed cirrhosis treated at Hanoi Medical University Hospital and Bach Mai Hospital from August 2023 to August 2024. Results: 305 patients were included in the study. The mean age was 57.6 ± 11.0 (16 - 101 years old). The male/female ratio was 5.22/1. The mean 5vMELD score was 21.3 ± 6.4. The 5vMELD score had a weak prognostic value at 30 days with AUROC 0.5259; 90-day medium prognostic value (AUROC 0.6276) (p>0.05). The 5vMELD score had the optimal predictive value at the cutoff point of 21, with a sensitivity of 70%, specificity of 46.78% at 30 days; and a sensitivity of 77.27%, specificity of 48.06% at 90 days. Conclusion: The 5vMELD score has low predictive value in predicting the prognosis of patients with cirrhosis./Further research is needed to determine the significance of the 5vMELD score in predicting the prognosis of patients with cirrhosis.

Article Details

Keywords

5vMELD, prediction, liver cirrhosis

References

Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749-1761.
2. Kim Y, Kim K, Jang I. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: A retrospective cohort study. Medicine (Baltimore). 2019;98(45):e17862.
3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864-871.
4. Myers RP, Tandon P, Ney M, et al. Validation of the five-variable Model for End-stage Liver Disease (5vMELD) for prediction of mortality on the liver transplant waiting list. Liver Int. 2014;34(8):1176-1183.
5. Myers RP, Shaheen AAM, Faris P, Aspinall AI, Burak KW. Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One. 2013;8(1):e51926.
6. Wiesner R, Edwards E, Freeman R, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003;124(1):91-96.
7. Tohidinezhad F, Eslami S, Abu-Hanna A, Aliakbarian M. Model for End-Stage Liver Disease and Seven Derivations to Prioritize Liver Transplant Candidates: Which Is the Winner? Exp Clin Transplant. 2018;16(6):721-729.
8. Montri D, Yaowadee T, Piyawat K. Modification of MELD score by including Serum Albumin to improve prediction of mortality outcome of cirrhotic patient based on Thai cirrhotic patients. 2014 11th International Joint Conference on Computer Science and Software Engineering (JCSSE). Published online January 1, 2014.
9. Nguyễn Thị Oanh, Nguyễn Thị Vân Hồng. Đánh giá điểm MELD, MELD Na ở bệnh nhân xơ gan có biến chứng. VMJ. 2021;498(1).
10. Dunn W, Jamil LH, Brown LS, et al. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology. 2005;41(2):353-358.